Skip to content

PATENTS

Product U.S. Patent
Edarbi® 7,157,584; 7,572,920; 9,066,936
Edarbyclor® 7,157,584; 7,572,920; 9,066,936; 9,169,238; 9,387,249
Epaned® 9,669,008; 9,808,442; 10,039,745; 10,154,987; 10,772,868; 10,786,482; 11,040,023; 11,141,405; 11,173,141; patents pending
Eprontia Patents pending
Evekeo ODT® 10,130,580; 10,441,554; 11,160,772; patents pending
Firvanq® 10,493,028; 10,688,046; 10,959,946; 10,959,947; 10,959,948; 10,959,949; 11,142,352; patents pending
Fleqsuvy 11,324,696; patents pending
Horizant® 6,818,787; 8,026,279; 8,048,917; 8,114,909; 8,686,034; 8,795,725; patents pending
Katerzia® 10,695,329; 10,799,453; 10,894,039; 10,952,998; 10,959,991; patents pending
Nymalize® 7,070,581; 8,517,997; 10,342,787; 10,576,070; patents pending
Qbrelis® 9,463,183; 9,616,096; 9,814,751; 10,039,800; 10,265,370; 10,406,199; 10,940,177; 11,179,434; patents pending
Sklice® 8,927,595; 8,791,153; 11,229,207; patents pending
Sotylize® 9,724,297; 10,206,895; 11,013,703; patents pending
Triptodur® 10,166,181; patents pending
Xatmep® 9,259,427; 9,855,215; 10,231,927; 10,610,485; patents pending

Edarbi® and Edarbyclor® are trademarks of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Arbor Pharmaceuticals, LLC.

Triptodur® is a registered trademark of Debiopharm International SA.